Morphic Holding (Morphic Holding) 3-Year Book Growth Rate : 45.70% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Morphic Holding 3-Year Book Growth Rate?

Morphic Holding's Book Value per Share for the quarter that ended in Mar. 2024 was $13.25.

During the past 12 months, Morphic Holding's average Book Value per Share Growth Rate was 23.10% per year. During the past 3 years, the average Book Value per Share Growth Rate was 45.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 7 years, the highest 3-Year average Book Value per Share Growth Rate of Morphic Holding was 45.70% per year. The lowest was 24.60% per year. And the median was 35.15% per year.

Competitive Comparison of Morphic Holding's 3-Year Book Growth Rate

For the Biotechnology subindustry, Morphic Holding's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Morphic Holding's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Morphic Holding's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Morphic Holding's 3-Year Book Growth Rate falls into.

Morphic Holding 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Morphic Holding (NAS:MORF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Morphic Holding 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Morphic Holding's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Morphic Holding (Morphic Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Morphic Holding Inc (NAS:MORF) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

31Y:Germany 31Y:Germany

Address

35 Gatehouse Drive, A2, Waltham, MA, USA, 02451

Website

http://www.morphictx.com

Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.

Executives

William Devaul	officer: General Counsel and Secretary	C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE, A2, WALTHAM MA 02451
Bruce Rogers	officer: Chief Scientific Officer	C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE, A2, WALTHAM MA 02451
Marc Schegerin	officer: CFO and COO	ARQULE INC, 1 WALL ST FL6, BURLINGTON MA 01803
Praveen P. Tipirneni	director, officer: President and CEO	C/O MORPHIC HOLDING, INC.,, 35 GATEHOUSE DRIVE, A2, WALTHAM MA 02451
Farrell Robert E Jr	officer: VP Finance and Ops, Secretary	CAMBRIDGE DISCOVERY PARK, 100 ACORN PARK DRIVE, 5TH FLOOR, CAMBRIDGE MA 02140
Joseph P Slattery	director	C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Martin Edwards	director	15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON MA 01803
Timothy A Springer	director, 10 percent owner	36 WOODMAN ROAD, CHESTNUT HILL MA 02467
Peter Linde	officer: Chief Medical Officer	C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE A2, WALTHAM ME 02451
Nisha Nanda	director	281 TRESSER BOULEVARD, STAMFORD CT 06901
Amir Nashat	director	10835 ROAD TO THE CURE, SUITE 205, SAN DIEGO CA 92121
Omega Fund V Gp, L.p.	director	888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Susannah Gray	director	10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO CA 92121
Vikas Goyal	director	C/O SR ONE, LTD., 161 WASHINGTON ST., SUITE 500, EIGHT TOWER BRIDGE, CONSHOHOCKEN PA 19428
Otello Stampacchia	director	888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199